Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Koller

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Brain and Behavior|August 14, 2020
Mental development is associated with cortical connectivity of the ventral and nonspecific thalamus of preterm newbornsAndras Jakab, Giancarlo Natalucci, Brigitte Koller, et al.
JAMA|December 8, 2020
Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm InfantsGiancarlo Natalucci, Bea Latal, Brigitte Koller, et al.
Pediatrics|August 5, 2008
An approach to using recombinant erythropoietin for neuroprotection in very preterm infantsJean-Claude Fauchère, Christof Dame, Reinhard Vonthein, et al.
JAMA Network Open|December 8, 2022
Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized Clinical TrialEleonora Picotti, Tilman Reinelt, Brigitte Koller, et al.
JAMA|May 18, 2016
Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical TrialGiancarlo Natalucci, Beatrice Latal, Brigitte Koller, et al.
Pediatric Research|April 9, 2013
Functional brain maturation assessed during early life correlates with anatomical brain maturation at term-equivalent age in preterm infantsGiancarlo Natalucci, Russia Ha-Vinh Leuchter, Hans Ulrich Bucher, et al.
Children (Basel, Switzerland)|May 31, 2017
Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter?Tiziana L Burkart, Andrea Kraus, Brigitte Koller, et al.
Neonatology|June 28, 2014
Randomized controlled trials in very preterm infants: does inclusion in the study result in any long-term benefit?Christoph M Rüegger, Andrea Kraus, Brigitte Koller, et al.
JAMA|August 27, 2014
Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent ageRussia Ha-Vinh Leuchter, Laura Gui, Antoine Poncet, et al.
BMC Pediatrics|January 21, 2014
Minimally invasive, imaging guided virtual autopsy compared to conventional autopsy in foetal, newborn and infant cases: study protocol for the paediatric virtual autopsy trialChristoph M Rüegger, Christine Bartsch, Rosa Maria Martinez, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Brain and Behavior|August 14, 2020
Mental development is associated with cortical connectivity of the ventral and nonspecific thalamus of preterm newbornsAndras Jakab, Giancarlo Natalucci, Brigitte Koller, et al.
JAMA|December 8, 2020
Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm InfantsGiancarlo Natalucci, Bea Latal, Brigitte Koller, et al.
Pediatrics|August 5, 2008
An approach to using recombinant erythropoietin for neuroprotection in very preterm infantsJean-Claude Fauchère, Christof Dame, Reinhard Vonthein, et al.
JAMA Network Open|December 8, 2022
Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized Clinical TrialEleonora Picotti, Tilman Reinelt, Brigitte Koller, et al.
JAMA|May 18, 2016
Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical TrialGiancarlo Natalucci, Beatrice Latal, Brigitte Koller, et al.
Pediatric Research|April 9, 2013
Functional brain maturation assessed during early life correlates with anatomical brain maturation at term-equivalent age in preterm infantsGiancarlo Natalucci, Russia Ha-Vinh Leuchter, Hans Ulrich Bucher, et al.
Children (Basel, Switzerland)|May 31, 2017
Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter?Tiziana L Burkart, Andrea Kraus, Brigitte Koller, et al.
Neonatology|June 28, 2014
Randomized controlled trials in very preterm infants: does inclusion in the study result in any long-term benefit?Christoph M Rüegger, Andrea Kraus, Brigitte Koller, et al.
JAMA|August 27, 2014
Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent ageRussia Ha-Vinh Leuchter, Laura Gui, Antoine Poncet, et al.
BMC Pediatrics|January 21, 2014
Minimally invasive, imaging guided virtual autopsy compared to conventional autopsy in foetal, newborn and infant cases: study protocol for the paediatric virtual autopsy trialChristoph M Rüegger, Christine Bartsch, Rosa Maria Martinez, et al.
Pageof 1